6-Chloro-2-(1,3-dimethyl-1H-pyrazol-4-yl)-7-(4-(pyrazin-2-ylmethyl)piperazin-1-yl)-3H-imidazo[4,5-b]pyridine

Catalog No. :
ACRSOQ536
CAS No. :
1402709-95-8
Molecular Formula :
C20H22ClN9
Molecular Weight :
423.91

IUPAC Name:6-chloro-2-(1,3-dimethyl-1H-pyrazol-4-yl)-7-(4-(pyrazin-2-ylmethyl)piperazin-1-yl)-3H-imidazo[4,5-b]pyridine

6-Chloro-2-(1,3-dimethyl-1H-pyrazol-4-yl)-7-(4-(pyrazin-2-ylmethyl)piperazin-1-yl)-3H-imidazo[4,5-b]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Chloro-2-(1,3-dimethyl-1H-pyrazol-4-yl)-7-(4-(pyrazin-2-ylmethyl)piperazin-1-yl)-3H-imidazo[4,5-b]pyridine
IUPAC Name6-chloro-2-(1,3-dimethyl-1H-pyrazol-4-yl)-7-(4-(pyrazin-2-ylmethyl)piperazin-1-yl)-3H-imidazo[4,5-b]pyridine
MDL No.-
Molecular FormulaC20H22ClN9
Molecular Weight423.91
SMILESCC1=NN(C)C=C1C2=NC3=C(N4CCN(CC5=NC=CN=C5)CC4)C(Cl)=CN=C3N2
InChI KeyYSOVGVFBIJMIIQ-UHFFFAOYSA-N
Synonym6-Chloro-2-(1,3-dimethyl-1H-pyrazol-4-yl)-7-[4-(2-pyrazinylmethyl)-1-piperazinyl]-3H-imidazo[4,5-b]pyridine;6-Chloro-2-(1,3-dimethyl-4-pyrazolyl)-7-[4-(2-pyrazinylmethyl)-1-piperazinyl]-3H-imidazo[4,5-b]pyridine
CAS No.1402709-95-8

Synthetic Route by SureRoute

1. ACRSOQ536 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMJYW651 route compound structure diagram
    ACMJYW6515780-66-5 In Stock
  4. Then
  5. ACRSOQ536 route product structure diagram
    ACRSOQ5361402709-95-8
Inquiry

2. ACRSOQ536 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRKYU478 route compound structure diagram
    ACRKYU4786705-33-5 In Stock
  4. Then
  5. ACRSOQ536 route product structure diagram
    ACRSOQ5361402709-95-8
Inquiry

Comments (0)